Robert J. Ferrante

34.2k citations

160 papers · 26.2k indexed · 10 hit papers · h-index 85

Cellular and Molecular Neuroscience top 0.02%
- Genetic Neurodegenerative Diseases 88
- Neuroscience and Neuropharmacology Research 18
Neurology top 0.02%
- Amyotrophic Lateral Sclerosis Research 34
- Parkinson's Disease Mechanisms and Treatments 31
- Neurological disorders and treatments 27
Neurology top 0.1%
- Amyotrophic Lateral Sclerosis Research 34
- Parkinson's Disease Mechanisms and Treatments 31
- Neurological disorders and treatments 27
Biological Psychiatry top 0.5%
Molecular Biology top 0.1%
- Mitochondrial Function and Pathology 69
- Muscle Physiology and Disorders 11
Genetics
- Neurogenetic and Muscular Disorders Research 15

Co-authors: M. Flint Beal Neil W. Kowall Steven M. Hersch Ole A. Andreassen Edward P. Richardson Hoon Ryu Jean‐Paul Vonsattel Edward D. Bird
Cited by: Cellular and Molecular Neuroscience Neurology
Journals: Journal of Neurochemistry (21 papers)Journal of Neuroscience (18 papers)Proceedings of the National Academy of Sciences (9 papers)
Partner nations: United States France Switzerland

In The Last Decade

Robert J. Ferrante

160 papers receiving 25.7k citations

Hit Papers

10 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2003 Science
2003 Journal of Neuroscience
2002 Nature
2000 Nature Medicine
2000 Journal of Neuroscience
1999 Journal of Neuroscience
1999 Nature Medicine
1997 Journal of Neurochemistry
1996 Nature Genetics
1985 Journal of Neuropathology & Experimental Neurology

Peers

Countries citing papers authored by Robert J. Ferrante

Since Specialization

Citations

This map shows the geographic impact of Robert J. Ferrante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Ferrante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Ferrante more than expected).

Fields of papers citing papers by Robert J. Ferrante

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Ferrante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Ferrante. The network helps show where Robert J. Ferrante may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert J. Ferrante, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert J. Ferrante Line = papers co-authored together Robert J. Ferrante links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	MAP Kinase Phosphatase 1 (MKP-1/DUSP1) Is Neuroprotective in Huntington's Disease via Additive Effects of JNK and p38 Inhibition Journal of Neuroscience ·David Taylor,Roger Moser,Etienne Régulier,Lionel Breuillaud,Meredith Dixon,雅敏橘,Linda Elliston,王小兰,Jinho Kim,Lesley Jones,Daniel R. Goldstein,Robert J. Ferrante,Ruth Luthi‐Carter	2013	94
2	Transcriptional modulator H2A histone family, member Y ( H2AFY ) marks Huntington disease activity in man and mouse Proceedings of the National Academy of Sciences ·Yi Hu,Vanita Chopra,Raman Chopra,Joseph J. Locascio,Zhixiang Liao,Hongliu Ding,Bin Zheng,Wayne R. Matson,Robert J. Ferrante,H. Diana Rosas,Steven M. Hersch,Clemens R. Scherzer	2011	76
3	The Melatonin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity Journal of Neuroscience ·Xin Wang,Jilong Kuang,Masaki Fukunaga,Kerry Cormier,Karen Smith,Jiying Jiang,Shuanhu Zhou,Hui Wang,Rong Zhao,Hiroko Yano,Jeong Eun Kim,Wei Li,Bruce S. Kristal,Robert J. Ferrante,Robert M. Friedlander	2011	156
4	In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects Human Molecular Genetics ·Mathilde Faideau,Jae-Hwan Kim,Kerry Cormier,Reid Gilmore,T Isa,Gwennaëlle Aurégan,Noëlle Dufour,Martine Guillermier,Emmanuel Brouillet,Philippe Hantraye,Nicole Déglon,Robert J. Ferrante,Gilles Bonvento	2010	250
5	Inhibitors of CytochromecRelease with Therapeutic Potential for Huntington's Disease Journal of Neuroscience ·Xin Wang,Shan Zhu,Masaki Fukunaga,S.O. DeLong,Irina G. Stavrovskaya,Steven J. Del Signore,Kerry Cormier,A. Suozzi,Hongyan Wang,Robert J. Ferrante,Bruce S. Kristal,Robert M. Friedlander	2008	100
6	Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Edward C. Stack,I Made Suparta Utama,Jin-Ho Kim,Steven J. Del Signore,Sarah Goodrich,Samantha Matson,Eleanor Marguerite Pratt,Kerry Cormier,Karen Smith,Wayne R. Matson,Hoon Ryu,Robert J. Ferrante	2008	47
7	Neuroprotective Effects of Synaptic Modulation in Huntington's Disease R6/2 Mice Journal of Neuroscience ·Edward C. Stack,Alpaslan Dedeoglu,Karen Smith,Kerry Cormier,James K. Kubilus,Mikhail Bogdanov,Wayne R. Matson,Lichuan Yang,Bruce G. Jenkins,Ruth Luthi‐Carter,Neil W. Kowall,Steven M. Hersch,M. Flint Beal,Robert J. Ferrante	2007	61
8	Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Edward C. Stack,Karen Smith,Hoon Ryu,Kerry Cormier,Minghua Chen,MD WAQUAR TAIYEB,Steven J. Del Signore,Merit Cudkowicz,Robert M. Friedlander,Robert J. Ferrante	2005	94
9	Translating therapies for Huntington’s disease from genetic animal models to clinical trials Neurotherapeutics ·Steven M. Hersch,Robert J. Ferrante	2004	2
10	Translating therapies for Huntington’s disease from genetic animal models to clinical trials PubMed ·Steven M. Hersch,Robert J. Ferrante	2004	55
11	Chemotherapy for the Brain: The Antitumor Antibiotic Mithramycin Prolongs Survival in a Mouse Model of Huntington's Disease Journal of Neuroscience ·Robert J. Ferrante,Hoon Ryu,James K. Kubilus,Santosh R. D’Mello,Katharine L. Sugars,Junghee Lee,Peiyuan Lu,Karen Smith,Susan Browne,M. Flint Beal,Bruce S. Kristal,Irina G. Stavrovskaya,Sandra J. Hewett,David C. Rubinsztein,Brett Langley,Rajiv R. Ratan	2004	172
12	Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Micebreakdown → Science ·Albrecht M. Clement,Minh Dang Nguyen,Elizabeth A. Roberts,Michael L. Garcia,Séverine Boillée,Elsbeth Duke,Andrew P. McMahon,Wilder T. Doucette,Donald Siwek,Robert J. Ferrante,Robert H. Brown,Jean‐Pierre Julien,Lawrence S.B. Goldstein,Don W. Cleveland	2003	855
13	Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway Proceedings of the National Academy of Sciences ·Hoon Ryu,Jung-Hee Lee,Beatrix A. Olofsson,Yendouhame Kombate,Дудаев Анатолий Борисович,Е. С. Волкова,Erik K. Flemington,Jane Azizkhan‐Clifford,Robert J. Ferrante,Rajiv R. Ratan	2003	225
14	The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: Neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis Proceedings of the National Academy of Sciences ·Sébastien Holbert,Michelot Michel,Resolve Team,Adam Rosenblatt,Cheryl L. Wellington,Michael R. Hayden,Russell L. Margolis,Christopher A. Ross,J Dausset,Robert J. Ferrante,Christian Néri	2001	143
15	Transgenic ALS Mice Show Increased Vulnerability to the Mitochondrial Toxins MPTP and 3-Nitropropionic Acid Experimental Neurology ·Ole A. Andreassen,Robert J. Ferrante,Péter Klivènyi,Autumn Klein,Alpaslan Dedeoglu,David S. Albers,Neil W. Kowall,M. Flint Beal	2001	19
16	Neuronal Nitric Oxide Synthase Activation and Peroxynitrite Formation in Ischemic Stroke Linked to Neural Damage Journal of Neuroscience ·Mikael J. L. Eliasson,Zhihong Huang,Robert J. Ferrante,Masao Sasamata,Mark E. Molliver,Solomon H. Snyder,Michael A. Moskowitz	1999	309
17	Transgenic mice expressing a dominant negative mutant interleukin-1β converting enzyme show resistance to MPTP neurotoxicity Neuroreport ·Emília Pessoa Perez,Ole A. Andreassen,Robert J. Ferrante,Mike Kleine,Robert M. Friedlander,M. Flint Beal	1999	68
18	Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis Annals of Neurology ·M. Flint Beal,Robert J. Ferrante,Susan Browne,Russell T. Matthews,Neil W. Kowall,Robert H. Brown	1997	479
19	Inhibition of white blood cell adhesion at reperfusion decreases tissue damage in postischemic striated muscle Journal of Vascular Surgery ·Robert J. Ferrante,Robert W. Hobson,Masayuki Miyasaka,D. Neil Granger,Walter N. Durán	1996	22
20	Excitotoxin Lesions in Primates as a Model for Huntington's Disease: Histopathologic and Neurochemical Characterization Experimental Neurology ·Robert J. Ferrante,Neil W. Kowall,Filip Krsmanovic,Elsdon Storey,M. Flint Beal	1993	185

About Robert J. Ferrante

Robert J. Ferrante is a scholar working on Cellular and Molecular Neuroscience, Neurology and Genetics, having authored 160 papers that have together received 26.2k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (88 papers), Mitochondrial Function and Pathology (69 papers), Amyotrophic Lateral Sclerosis Research (34 papers), Parkinson's Disease Mechanisms and Treatments (31 papers), Neurological disorders and treatments (27 papers), Neuroscience and Neuropharmacology Research (18 papers), Neurogenetic and Muscular Disorders Research (15 papers) and Muscle Physiology and Disorders (11 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (13.0k citations), Neurology (9.8k citations) and Neurology (3.1k citations). Robert J. Ferrante has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include M. Flint Beal, Neil W. Kowall, M. Flint Beal, Steven M. Hersch, Ole A. Andreassen, Edward P. Richardson, Hoon Ryu, Jean‐Paul Vonsattel, Edward D. Bird and Alpaslan Dedeoglu. Their work appears in journals such as Journal of Neurochemistry, Journal of Neuroscience, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuropathology & Experimental Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact